- Chief Executive Officer of Hevolution Foundation
Dr Khan’s career has included a number of senior corporate roles, including Vice Chairman and Chief Scientific Officer of Global Research and Development at PepsiCo, and President of Global R&D Center, at Takeda Pharmaceuticals. He is also currently the Executive Chairman of Life Biosciences Inc.
Before moving into industry Dr Khan was a faculty member in endocrinology at the Mayo Clinic and Mayo Medical School where he served as Director of the Diabetes, Endocrine and Nutritional Trials Unit. He also led programs in diabetes, endocrinology, metabolism and nutrition in Minneapolis. He is a member of the Board of Directors of Reckitt Benckiser; Chairman of the Visiting Committee on Advanced Technology of the United States’ National Institute of Standards and Technology, a member of the Saudi RDI Supreme Committee and a member of The Saudi National Biotechnology Strategy Steering Committee.
Dr Khan earned his medical degree from the University of Liverpool Medical School, England, and completed a fellowship in clinical endocrinology and nutrition in the Department of Medicine and Food Science and Nutrition at the University of Minnesota, Minneapolis.
He is a Fellow of the Royal College of Physicians in London and a Fellow of the American College of Endocrinology.